Gothenburg, November 3, 2020. The Board of Directors of Heliospectra AB (publ)("Heliospectra" or "the Company") has prepared a prospectus regarding the issue of shares and warrants ("Units") with preferential rights for existing shareholders (the "Rights Issue") published on 25 September 2020.
The prospectus has been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen).The prospectus regarding Heliospectra's rights issue will be available on Heliospectra's website (www.heliospectra.com), Västra Hamnen Corporate Finance website (www.vhcorp.se) and on the Swedish Financial Supervisory Authority's website (www.fi.se).
Västra Hamnen Corporate Finance AB is afinancial advisor and MAQS Advokatbyrå is legal advisor to Heliospectra inconnection with the Rights Issue.
Ali Ahmadian, CEO of Heliospectra
+46 (0)72 203 6344
The information wassubmitted for publication, through the agency of the contact person set outabove, at 09:45 CET on November 3, 2020.
HeliospectraAB (publ) (OTCQB: HLS, FIRST NORTH:HELIO) is the global leader in intelligent lighting technology, light controlsystems and related services for greenhouse and controlled plant growthenvironments. With the vision to make commercial crop production more connectedand resource-efficient, Heliospectra integrates customized LED spectralstrategies with real-time response and artificial intelligence to createpredictable and reliable business forecasts and harvest results. Founded in2006, Heliospectra is committed to helping growers and commercial producersacross six continents consistently increase yields and produce crops withquality appearance, superior nutritional or medicinal value and longer shelflife, harvest after harvest. Heliospectra is the recipient of multipleinternational awards and recognitions. For more information, please visit https://www.heliospectra.com.
Redeye isHeliospectra's Certified Adviser on Nasdaq First North Growth Market
Certifiedadviser@redeye.se | +46 (0) 8 121 576 90
Important information
This press release does not constitute an offer for any securities inHeliospectra. The issue is not directed to shareholders or other investorsresiding in the United States, Australia, Hong Kong, Japan, Canada, Singapore,South Africa or New Zealand, or in any other country where participation in theissue would require additional prospectuses, registration or other measuresthan Swedish law or conflict with rules in such country. No subscriptionrights, paid subscription shares, shares or other securities issued byHeliospectra have been registered or will be registered under the United StatesSecurities Act 1933, or under the securities legislation in any state in theUnited States or any province law in Canada. Therefore, no subscription rights,paid subscribed shares, shares or other securities issued by Heliospectra maybe transferred or offered for sale in the United States or Canada other than insuch exceptional cases that do not require registration. The issue is onlyaimed at (i) persons who are outside the UK; (ii) to professional investorscovered by Article 19 (5) of the Financial Services and Markets Act 2000(Financial Promotion) Order 2005 (in its current wording); or (iii) otherpersons to whom it may lawfully be directed.